TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05369182

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive physiologic assessment
Description: All coronary physiologic parameters are measured following diagnostic angiography. Resting pd/pa, FFR, CFR and IMR will be calculated using coronary physiologic parameters.~In patients treated by PCI, post-PCI physiologic assessment including CFR, IMR, and FFR will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive physiologic assessment
Description: All coronary physiologic parameters are measured following diagnostic angiography. Resting pd/pa, FFR, CFR and IMR will be calculated using coronary physiologic parameters.~In patients treated by PCI, post-PCI physiologic assessment including CFR, IMR, and FFR will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive physiologic assessment
Description: All coronary physiologic parameters are measured following diagnostic angiography. Resting pd/pa, FFR, CFR and IMR will be calculated using coronary physiologic parameters.~In patients treated by PCI, post-PCI physiologic assessment including CFR, IMR, and FFR will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive physiologic assessment
Description: All coronary physiologic parameters are measured following diagnostic angiography. Resting pd/pa, FFR, CFR and IMR will be calculated using coronary physiologic parameters.~In patients treated by PCI, post-PCI physiologic assessment including CFR, IMR, and FFR will be performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Intravascular imaging
Description: By the operator's discretion, stent-optimization will be performed under intravascular imaging devices (IVUS \[Boston Scientific, Natick, Massachusetts, USA\] or OCT \[Abbott Vascular\], St. Paul, MN, USA\]).
Study: NCT05237375

Intervention type: OTHER
Intervention: The MIDWIZE model
Description: So-called MIDWIZE ambassadors are planned to be appointed to lead the clinical implementation of the quality improvement components.~Initial training workshops will be held with the ambassadors on practical aspects of the chosen components and how to explain their benefits to the units' staff. Training will also be provided on how to enhance interdisciplinary teamwork and coordinate quality improvements. The workshops will be held onsite at Naguru hospital and online via the project's MIDWIZE virtual platform. The ambassadors will themselves hold training workshops to support midwives and other healthcare providers at the clinics during the implementation of the quality improvements components. The virtual MIDWIZE platform will contain videos, posters, presentations, and other training material that the ambassadors can utilise to enhance the units' capacity and engage their colleagues.
Study: NCT05626270

Intervention type: DEVICE
Group type: OTHER
Intervention: LunulaLaser OTC
Description: The LunulaLaser™ OTC is a nonthermal and non-invasive procedure designed to restore the growth of clear, healthy nails in clients with onychomycosis.
Study: NCT06424184

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Accelerated Repetitive Transcranial Magnetic Stimulation
Description: The rTMS protocol implemented in this study will include approximately 10-minute long sessions of intermittent theta burst stimulation (iTBS) with at least 50 minutes in between iTBS sessions.~Study participants will receive the rTMS intervention for up to 50 sessions across a three-week period. The total of 50 sessions will be administered as up to 4 sessions each day, up to 5 days per week over an up to 3-week-long period.
Study: NCT05087550

Intervention type: PROCEDURE
Intervention: Liver Transplantation
Description: Patients who underwent liver transplantation at Methodist Dallas Medical Center
Study: NCT06148454

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-based Positive Psychology Intervention (A&B)
Description: An app-based, evidence-based positive psychology intervention focusing on two modules: (A) Awareness \& Positivity and (B) Meaning and Accomplishment

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-based Positive Psychology Intervention (C&D)
Description: An app-based, evidence-based positive psychology intervention focusing on two modules: (C) Rapport \& Conflict Management and (D) Compassion \& Leadership
Study: NCT06490835

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-quality palliative care through consultation-based palliative care services in the ICU
Description: Family Counseling: Social workers implement a supportive process for families, assessing the individualized psychosocial and decisional support needs of patients and families to provide foundational data for palliative care consultations.~Family Meeting Support: In cases of high medical complexity, uncertainty, value conflicts, or communication issues, the palliative care consultation team supports the facilitation of family meetings.~Consultation: The palliative care team provides consultations to the attending physician based on the palliative care needs assessed during family counseling. Topics include symptom management, understanding treatment options, decisional conflict, emotional and practical support, goal of care setting, resources, and bereavement support.~Palliative Care by attending Physician: The attending physician incorporates the consultations received from the palliative care consultation team to provide high-quality palliative care to patients and their families.
Study: NCT06004843

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remimazolam
Description: in this group,patients are treated with remimazolam and remifentanil for reduced sedation.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: in this group,patients are treated with propofol and remifentanil for reduced sedation.
Study: NCT05998421

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: The patients in the acupuncture group accepted acupuncture treatment weekly from the second day of menstruation and three times in one cycle. Seirin 0.2-×30-mm acupuncture needles were used. First, needles were inserted into Shenting (GV 24) and bilateral Benshen (G 13) to relieve uneasiness of mind. Then, they were inserted into Chung wan (cv 12), Qihai (CV6), Guan yuan, chung chi (cv 3), bilateral Guiai (S 29) and Zigong (Extra 16) to recuperate energy. Finally, bilateral Tsusanli (st 36), Yinlingch'uan (sp 9) and San yin chiao (sp 6) were used to soothe the liver and tonify the spleen and kidney. Each acupuncture treatment session lasted 30 minutes, with mostly bilateral needle retention over 20-30 minutes for evens techniques.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: routine aspirin and heparin treatment
Description: The patients accepted routine aspirin and heparin treatment. Two months before pregnancy, 50 mg of aspirin (Chenxin Pharmaceutical, China) was taken orally once a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: routine aspirin and heparin treatment
Description: The patients accepted routine aspirin and heparin treatment. Two months before pregnancy, 50 mg of aspirin (Chenxin Pharmaceutical, China) was taken orally once a day.
Study: NCT05033470

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dabir Mattress Overlay System
Description: Dabir Surface mattress overlay system consists of a controller and a low-profile alternating pressure (AP) surface (placed over a non-powered mattress) with hundreds of air-filled geometric nodes arranged in rows. . The multiple rows of nodes inflate and deflate in alternating sequence every five minutes. During deflation phase, the skin and soft tissues experience reduced pressure/loading and enhanced perfusion. In conjunction with Standard of Care: Debridement, Proper moisture balance, off-loading, reduce bacterial burden and nutritional counseling.
Study: NCT05511272

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: blood test
Description: four blood samples will be withdrawn from the participants during the day of their frozen embryo transfer cycle
Study: NCT05466864

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Belun Sleep platform
Description: BSP(Belun Technology Company Limited) is a novel wearable system using a neural network algorithm that consists of a patented wearable device (Belun Ring), a charging cradle, and cloud-based software. The Belun Ring, an FDA-cleared pulse oximeter, acquires signals from the radialis indicis artery of the proximal index finger. The Belun Ring total sleep time can be derived from features extracted from accelerometer, SpO2, and PPG signals, whereas Belun Ring AHI can be derived from Ring-TST and features extracted from HRV and SpO2 changes. The BSP proprietary OSA detection algorithm was using neural network. BSP performance can be improved by training the algorithm through continual data collection. To our knowledge, BSP is the only validated sleep platform using a medical-grade wearable pulse oximeter, actigraphy, and artificial intelligence algorithm that has the capability to identify sleep stages, detect OSA events, and monitor autonomic nervous system activity changes during sleep.
Study: NCT04631211

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thrombosomes
Description: Human platelet derived lyophilized hemostatic

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thrombosomes
Description: Human platelet derived lyophilized hemostatic
Study: NCT04861298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: standard of care for COVID-19 as per the hospital guidelines
Description: Hospital standard of care treatment for COVID-19

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard of care for COVID-19 as per the hospital guidelines
Description: Hospital standard of care treatment for COVID-19

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin Phytosome (QP)
Description: Daily dose of 600 mg of Quercetin for 1st week and then 400 mg for the 2nd week
Study: NCT05395507

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Recombinant Interferon Alpha
Description: Recombinant Interferon Alpha, with an initial dose of 300 wu three times a week. Other interferons that have been listed can be used if Recombinant Interferon Alpha (300 wu) is not available.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated interferon alfa-2b
Description: Pegylated Interferon Alfa-2b, with an initial dose of 135 ug at week 0 , and then 180 ug once a week from week 1 to week 52.
Study: NCT06112145

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rehabilitation program
Description: All fingers of the injured hand are fitted with a dorsal blocking orthosis. Early passive mobilization exercises in the form of passive flexion and extension and edema massage will be taught and it will be recommended to be applied every two hours during the day.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rehabilitation program
Description: All fingers of the injured hand are fitted with a dorsal blocking orthosis. Early passive mobilization exercises in the form of passive flexion and extension and edema massage will be taught and it will be recommended to be applied every two hours during the day.
Study: NCT04631211

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thrombosomes
Description: Human platelet derived lyophilized hemostatic

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Liquid Stored Platelets (LSP)
Description: Leukocyte reduced apheresis platelets or whole blood derived pooled platelet concentrate equivalent (4-6 units)
Study: NCT05942495

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: short-term schema focused group therapy
Description: There are two intervention phases. The first concerns the pre-treatment phase, which consists of five online sessions and three face-to-face sessions. The second intervention phase is the short-term SFGT. The SFGT consists of 17 weekly group sessions.
Study: NCT05590078

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality session
Description: The 20-minute virtual reality session, in the outpatient department before surgery, immerses the patient in calm environments combined with music therapy and breathing exercises to relax and reduce anxiety.

Intervention type: OTHER
Group type: OTHER
Intervention: State Trait Anxiety Inventory
Description: The State Trait Anxiety Inventory (State anxiety) is a questionnaire given to adults that shows how strong a person's feelings of anxiety are right now, just now. The score is measured on arrival in the outpatient department and just before going into the intervention room (= after the virtual reality session for the experimental group)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: State Trait Anxiety Inventory
Description: The State Trait Anxiety Inventory (State anxiety) is a questionnaire given to adults that shows how strong a person's feelings of anxiety are right now, just now. The score is measured on arrival in the outpatient department and just before going into the intervention room (= after the virtual reality session for the experimental group)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Satisfaction Score
Description: Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding virtual reality session

Intervention type: OTHER
Group type: OTHER
Intervention: Perioperative care satisfaction score
Description: Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding perioperative care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perioperative care satisfaction score
Description: Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding perioperative care
Study: NCT05345964

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GST-HG151
Description: Subjects will take GST-HG151 orally(once daily) on Day 1

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will take Placebo orally(once daily) on Day 1

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GST-HG151
Description: Subjects will take GST-HG151 orally (once daily) from Day 1 to Day 7

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will take Placebo orally (once daily) from day 1 to day 7

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GST-HG151
Description: Group A was administered under the fasting condition of Day1 in the first cycle, and under the postprandial conditions of Day8 \~ Day15 in the second cycle. The two cycles are cross-administered, and the cleaning period is 7 to 14 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GST-HG151
Description: Group B was administered under the postprandial conditions of Day1 in the first cycle, and under the sky-abdominal conditions of Day8 \~ Day15 in the second cycle. The two cycles are cross-administered, and the cleaning period is 7 to 14 days.
Study: NCT06493968

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxytocin
Description: Uterotonics will be given in the form of an IV bolus of 10 units of oxytocin immediately with the uterine incision

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: IV bolus of normal saline immediately with the uterine incision
Study: NCT04432883

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Experimental: Active cathodal tDCS + language training
Description: Cathodal tDCS raises neuronal membrane potentials, leading to decreased probability of depolarization from incoming stimuli.~Speech and Language training involves a combined semantic feature analysis and phonological components analysis treatment.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator: Placebo cathodal tDCS + Speech and language
Description: Speech and Language training involves a combined semantic feature analysis and phonological components analysis treatment. .
Study: NCT05839873

Intervention type: DEVICE
Intervention: FlexAbility SE Ablation Catheter
Description: Subjects receive ablation treatment.
Study: NCT06079450

Intervention type: OTHER
Intervention: artificial intelligence based mobile application
Description: Artificial intelligence-based mobile application developed by me that includes diabetes education for individuals with diabetes.
Study: NCT05142527

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADM03820
Description: ADM03820 is a 1:1 mixture of two human IgG1 non-competitive binding anti-SARS-CoV-2 antibodies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADM03820
Description: ADM03820 is a 1:1 mixture of two human IgG1 non-competitive binding anti-SARS-CoV-2 antibodies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study: NCT04220957

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Impression Technique
Description: Digital impressions of both arches will be taken by using an intraoral scanner (Trios 3, 3Shape, Denmark) by adhering to the scanning pattern recommended by the company for routine diagnosis and recording.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Impression Technique
Description: Conventional Impression Technique of both arches will be taken with alginate (Orthoprint, Zhermack) on conventional stainless steel impression trays.
Study: NCT05773001

Intervention type: DRUG
Group type: OTHER
Intervention: Ozone
Description: Subjects will perform alternating 15 minutes rest with 15 minutes treadmill walk exercise periods for 135 minutes in while breathing Ozone (O3).

Intervention type: DRUG
Group type: OTHER
Intervention: Ozone
Description: Subjects will perform alternating 15 minutes rest with 15 minutes treadmill walk exercise periods for 135 minutes in while breathing Ozone (O3).

Intervention type: DRUG
Group type: OTHER
Intervention: Ozone
Description: Subjects will perform alternating 15 minutes rest with 15 minutes treadmill walk exercise periods for 135 minutes in while breathing Ozone (O3).
Study: NCT05697601

Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial-Intelligence Based Screening Tools
Description: Artificial-Intelligence Based Screening Tools build on machine learning models

Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial-Intelligence Based Screening Tools
Description: Artificial-Intelligence Based Screening Tools build on machine learning models

Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial-Intelligence Based Screening Tools
Description: Artificial-Intelligence Based Screening Tools build on machine learning models

Intervention type: DIAGNOSTIC_TEST
Intervention: Pathology analysis
Description: Pathology assessment of cells and tissues from respective organs

Intervention type: DIAGNOSTIC_TEST
Intervention: Pathology analysis
Description: Pathology assessment of cells and tissues from respective organs

Intervention type: DIAGNOSTIC_TEST
Intervention: Pathology analysis
Description: Pathology assessment of cells and tissues from respective organs
Study: NCT05015088

Intervention type: OTHER
Intervention: No interventions will be performed in this study
Description: This study will not include any intervention
Study: NCT05949905

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: The intervention would be using the Processes of Change that match each Stage of Change.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: The intervention would be using the Processes of Change that match each Stage of Change.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: The intervention would be using the Processes of Change that match each Stage of Change.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: The intervention would be using the Processes of Change that match each Stage of Change.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: The intervention would be using the Processes of Change that match each Stage of Change.
Study: NCT05354362

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ATG-010 and ATG-008
Description: Patients enrolled will receive consecutive daily treatment at assigned dose level. The starting dose of ATG-010 at the dose escalation phase will be 60 mg QW, which could be escalated to 80 mg QW, 100 mg QW, 60 mg BIW. In case 60 mg QW of ATG-010 with any dose of ATG-008 is NOT tolerable, 40 mg QW ATG-010 could be explored. The starting dose of ATG-008 will be 15 mg QD, which could be escalated to 20 mg QD, with maximum of 30 mg QD. SRC will be consulted before each dose escalation starts.
Study: NCT06371001

Intervention type: OTHER
Intervention: disease
Description: Helicobacter Pylori Infection In Chonic Kidney Diseased Patien

Intervention type: OTHER
Intervention: disease
Description: Helicobacter Pylori Infection In Chonic Kidney Diseased Patien
Study: NCT05997303

Intervention type: OTHER
Group type: OTHER
Intervention: Continuous norepinephrine infusion via an infusion pump
Description: Patients will be randomized 1:1 to continuous norepinephrine infusion via an infusion pump or to manual bolus norepinephrine administration. The norepinephrine dose will be at the discretion of the treating anesthesiologists.

Intervention type: OTHER
Group type: OTHER
Intervention: Manual bolus norepinephrine administration
Description: Patients will be randomized 1:1 to continuous norepinephrine infusion via an infusion pump or to manual bolus norepinephrine administration. The norepinephrine dose will be at the discretion of the treating anesthesiologists.